What We're Reading: CBP Rejects Migrant Vaccination; PhRMA Cuts Funding for APF; Cancer Incidence by Chemical Plant
US Customs and Border Protection rejected recommendations by the CDC to vaccinate migrants in detention centers for the flu; PhRMA cut its donation to Addiction Policy Forum and will end all support in 2020; Louisiana health officials announced they will examine the cancer incidence in an area next to a chemical plant known to emit a likely carcinogen.
CBP Rejects CDC Recommendation to Vaccinate Migrants
Last winter, the CDC recommended the US Customs and Border Protection (CBP) to vaccinate migrants in detention against the flu, but CBP rejected the idea, according to a letter acquired by
PhRMA Cuts Donation for Addiction Treatment Group
PhRMA announced it will cut its donation for Addiction Policy Forum (APF) from $8.1 million to $6 million this year and will end all support in 2020, according to
Louisiana Officials to Examine Risk of Cancer by Chemical Plant
Louisiana health officials announced their intention to examine every residence within 2.5 kilometers of the chemical plant Denka Performance Elastomer in St. John the Baptist Parish to determine how many people in the neighborhood have developed cancer, according to
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Iron Dysregulation Linked to MS Progression, Review Finds
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025